Literature DB >> 25863357

Inhibition of 14-3-3 Proteins Leads to Schizophrenia-Related Behavioral Phenotypes and Synaptic Defects in Mice.

Molly Foote1, Haifa Qiao1, Kourtney Graham1, Yuying Wu1, Yi Zhou2.   

Abstract

BACKGROUND: The 14-3-3 family of proteins is implicated in the regulation of several key neuronal processes. Previous human and animal studies suggested an association between 14-3-3 dysregulation and schizophrenia.
METHODS: We characterized behavioral and functional changes in transgenic mice that express an isoform-independent 14-3-3 inhibitor peptide in the brain.
RESULTS: We recently showed that 14-3-3 functional knockout mice (FKO) exhibit impairments in associative learning and memory. We report here that these 14-3-3 FKO mice display other behavioral deficits that correspond to the core symptoms of schizophrenia. These behavioral deficits may be attributed to alterations in multiple neurotransmission systems in the 14-3-3 FKO mice. In particular, inhibition of 14-3-3 proteins results in a reduction of dendritic complexity and spine density in forebrain excitatory neurons, which may underlie the altered synaptic connectivity in the prefrontal cortical synapse of the 14-3-3 FKO mice. At the molecular level, this dendritic spine defect may stem from dysregulated actin dynamics secondary to a disruption of the 14-3-3-dependent regulation of phosphorylated cofilin.
CONCLUSIONS: Collectively, our data provide a link between 14-3-3 dysfunction, synaptic alterations, and schizophrenia-associated behavioral deficits. Published by Elsevier Inc.

Entities:  

Keywords:  14-3-3 Proteins; Dendritic spines; Neurotransmission; Prefrontal cortex; Schizophrenia; Transgenic mouse model

Mesh:

Substances:

Year:  2015        PMID: 25863357      PMCID: PMC4544659          DOI: 10.1016/j.biopsych.2015.02.015

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  66 in total

1.  Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display.

Authors:  B Wang; H Yang; Y C Liu; T Jelinek; L Zhang; E Ruoslahti; H Fu
Journal:  Biochemistry       Date:  1999-09-21       Impact factor: 3.162

2.  14-3-3 proteins mediate an essential anti-apoptotic signal.

Authors:  S C Masters; H Fu
Journal:  J Biol Chem       Date:  2001-09-27       Impact factor: 5.157

Review 3.  14-3-3 proteins in the nervous system.

Authors:  Daniela Berg; Carsten Holzmann; Olaf Riess
Journal:  Nat Rev Neurosci       Date:  2003-09       Impact factor: 34.870

Review 4.  From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.

Authors:  Bita Moghaddam; Daniel Javitt
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

5.  T-maze alternation in the rodent.

Authors:  Robert M J Deacon; J Nicholas P Rawlins
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1.

Authors:  Shinichiro Taya; Tomoyasu Shinoda; Daisuke Tsuboi; Junko Asaki; Kumiko Nagai; Takao Hikita; Setsuko Kuroda; Keisuke Kuroda; Mariko Shimizu; Shinji Hirotsune; Akihiro Iwamatsu; Kozo Kaibuchi
Journal:  J Neurosci       Date:  2007-01-03       Impact factor: 6.167

Review 7.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

Review 8.  Dendritic spine pathology in schizophrenia.

Authors:  J R Glausier; D A Lewis
Journal:  Neuroscience       Date:  2012-04-27       Impact factor: 3.590

9.  Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.

Authors:  Laure Verret; Edward O Mann; Giao B Hang; Albert M I Barth; Inma Cobos; Kaitlyn Ho; Nino Devidze; Eliezer Masliah; Anatol C Kreitzer; Istvan Mody; Lennart Mucke; Jorge J Palop
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

10.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.

Authors:  G Kirov; A J Pocklington; P Holmans; D Ivanov; M Ikeda; D Ruderfer; J Moran; K Chambert; D Toncheva; L Georgieva; D Grozeva; M Fjodorova; R Wollerton; E Rees; I Nikolov; L N van de Lagemaat; A Bayés; E Fernandez; P I Olason; Y Böttcher; N H Komiyama; M O Collins; J Choudhary; K Stefansson; H Stefansson; S G N Grant; S Purcell; P Sklar; M C O'Donovan; M J Owen
Journal:  Mol Psychiatry       Date:  2011-11-15       Impact factor: 15.992

View more
  27 in total

1.  14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.

Authors:  Bing Wang; Rachel Underwood; Anjali Kamath; Colleen Britain; Michael B McFerrin; Pamela J McLean; Laura A Volpicelli-Daley; Robert H Whitaker; William J Placzek; Katelyn Becker; Jiyan Ma; Talene A Yacoubian
Journal:  J Neurosci       Date:  2018-08-09       Impact factor: 6.167

Review 2.  Peptide regulation of cofilin activity in the CNS: A novel therapeutic approach for treatment of multiple neurological disorders.

Authors:  Alisa E Shaw; James R Bamburg
Journal:  Pharmacol Ther       Date:  2017-02-20       Impact factor: 12.310

3.  14-3-3θ Does Not Protect against Behavioral or Pathological Deficits in Alzheimer's Disease Mouse Models.

Authors:  Mary Gannon; Bing Wang; Sara Anne Stringfellow; Stephan Quintin; Itzel Mendoza; Thanushri Srikantha; A Claire Roberts; Takashi Saito; Takaomi C Saido; Erik D Roberson; Talene A Yacoubian
Journal:  eNeuro       Date:  2022-06-24

4.  Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains.

Authors:  Verônica M Saia-Cereda; Juliana S Cassoli; Andrea Schmitt; Peter Falkai; Juliana M Nascimento; Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-01       Impact factor: 5.270

Review 5.  Psychiatric disorders biochemical pathways unraveled by human brain proteomics.

Authors:  Verônica M Saia-Cereda; Juliana S Cassoli; Daniel Martins-de-Souza; Juliana M Nascimento
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-07-04       Impact factor: 5.270

Review 6.  14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases.

Authors:  F Sanders Pair; Talene A Yacoubian
Journal:  Trends Pharmacol Sci       Date:  2021-01-28       Impact factor: 14.819

7.  Impaired Object Recognition but Normal Social Behavior and Ultrasonic Communication in Cofilin1 Mutant Mice.

Authors:  A Özge Sungur; Lea Stemmler; Markus Wöhr; Marco B Rust
Journal:  Front Behav Neurosci       Date:  2018-02-19       Impact factor: 3.558

8.  Regulation of tyrosine hydroxylase is preserved across different homo- and heterodimeric 14-3-3 proteins.

Authors:  Sadaf Ghorbani; Agnete Fossbakk; Ana Jorge-Finnigan; Marte I Flydal; Jan Haavik; Rune Kleppe
Journal:  Amino Acids       Date:  2016-01-29       Impact factor: 3.520

9.  Dysregulated 14-3-3 Family in Peripheral Blood Leukocytes of Patients with Schizophrenia.

Authors:  Ying Qing; Liya Sun; Chao Yang; Jie Jiang; Xuhan Yang; Xiaowen Hu; Donghong Cui; Yifeng Xu; Lin He; Dongmei Han; Chunling Wan
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

10.  Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes.

Authors:  Juliana S Cassoli; Keiko Iwata; Johann Steiner; Paul C Guest; Christoph W Turck; Juliana M Nascimento; Daniel Martins-de-Souza
Journal:  Front Cell Neurosci       Date:  2016-03-03       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.